Kimmie Ng
#174,751
Most Influential Person Now
US physician at Dana–Farber Cancer Institute
Kimmie Ng's AcademicInfluence.com Rankings
Kimmie Ngphilosophy Degrees
Philosophy
#11482
World Rank
#15812
Historical Rank
Logic
#8294
World Rank
#10352
Historical Rank
Download Badge
Philosophy
Why Is Kimmie Ng Influential?
(Suggest an Edit or Addition)According to Wikipedia, Kimmie Ng is a physician at Dana–Farber Cancer Institute who is known for her work on colorectal cancer in young patients. Education and career Ng has an undergraduate degree from Yale University and earned her M.D. from the University of Pennsylvania in 2001. Subsequently she trained at the University of California, San Francisco and Dana–Farber Cancer Institute. In 2007, she received a masters in public health from Harvard University. As of 2021, Ng is a physician at the Dana–Farber Cancer Institute and a professor at Harvard Medical School. Ng is the director of Dana-Farber's Young-Onset Colorectal Cancer Center.
Kimmie Ng's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer (2017) (779)
- Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma (2016) (396)
- Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma (2016) (353)
- Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer. (2017) (313)
- Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer. (2008) (293)
- Phase II and pharmacodynamic study of autophagy inhibition using hydroxychloroquine in patients with metastatic pancreatic adenocarcinoma. (2014) (272)
- Predictive and Prognostic Roles of BRAF Mutation in Stage III Colon Cancer: Results from Intergroup Trial CALGB 89803 (2011) (258)
- Clinical activity of pertuzumab (rhuMAb 2C4), a HER dimerization inhibitor, in advanced ovarian cancer: potential predictive relationship with tumor HER2 activation status. (2006) (253)
- Association of Obesity With Risk of Early-Onset Colorectal Cancer Among Women (2019) (247)
- Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer. (2009) (219)
- Effect of Vitamin D Supplementation on Blood Pressure in Blacks (2013) (213)
- Real-time Genomic Characterization of Advanced Pancreatic Cancer to Enable Precision Medicine. (2018) (209)
- Rising incidence of early-onset colorectal cancer — a call to action (2020) (167)
- Detection of proximal adenomatous polyps with screening sigmoidoscopy: a systematic review and meta-analysis of screening colonoscopy. (2003) (126)
- Aspirin and COX-2 inhibitor use in patients with stage III colon cancer. (2015) (125)
- Association of Survival With Adherence to the American Cancer Society Nutrition and Physical Activity Guidelines for Cancer Survivors After Colon Cancer Diagnosis: The CALGB 89803/Alliance Trial (2018) (114)
- Vitamin D and colorectal cancer: molecular, epidemiological and clinical evidence (2016) (109)
- Spatially organized multicellular immune hubs in human colorectal cancer (2021) (109)
- Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial (2019) (106)
- Erratum: Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma (Cell Reports (2016) 15(4) (857–865) (S2211124716303643) (10.1016/j.celrep.2016.03.075)) (2016) (106)
- Plasma 25-Hydroxyvitamin D and Risk of Pancreatic Cancer (2011) (106)
- Prediagnostic body mass index and pancreatic cancer survival. (2013) (104)
- Development and Validation of the PREMM5 Model for Comprehensive Risk Assessment of Lynch Syndrome. (2017) (102)
- Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma (2017) (100)
- Efficacy and safety of single-agent pertuzumab (rhuMAb 2C4), a human epidermal growth factor receptor dimerization inhibitor, in castration-resistant prostate cancer after progression from taxane-based therapy. (2007) (99)
- Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer (2021) (95)
- PECAM-directed delivery of catalase to endothelium protects against pulmonary vascular oxidative stress. (2003) (92)
- Sedentary Behaviors, TV Viewing Time, and Risk of Young-Onset Colorectal Cancer (2018) (92)
- Plasma 25-hydroxyvitamin D and colorectal cancer risk according to tumour immunity status (2015) (89)
- Predicted vitamin D status and pancreatic cancer risk in two prospective cohort studies (2010) (86)
- Stereotactic Body Radiotherapy (SBRT) for Intrahepatic and Hilar Cholangiocarcinoma (2015) (85)
- Vitamin D status in patients with stage IV colorectal cancer: findings from Intergroup trial N9741. (2011) (85)
- Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer (2009) (81)
- Relationship between statin use and colon cancer recurrence and survival: results from CALGB 89803. (2011) (77)
- Factors That Contribute to Differences in Survival of Black vs White Patients With Colorectal Cancer. (2017) (77)
- Cell-Cycle-Targeting MicroRNAs as Therapeutic Tools against Refractory Cancers. (2017) (76)
- Cigarette Smoking and Pancreatic Cancer Survival. (2017) (76)
- Impact of Vitamin D Supplementation on Inflammatory Markers in African Americans: Results of a Four-Arm, Randomized, Placebo-Controlled Trial (2013) (76)
- Dose response to vitamin D supplementation in African Americans: results of a 4-arm, randomized, placebo-controlled trial. (2014) (72)
- Interaction of Molecular Markers and Physical Activity on Mortality in Patients with Colon Cancer (2009) (72)
- Clinical activity of gemcitabine plus pertuzumab in platinum-resistant ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. (2010) (71)
- Trastuzumab and tucatinib for the treatment of HER2 amplified metastatic colorectal cancer (mCRC): Initial results from the MOUNTAINEER trial (2019) (70)
- Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer (2010) (70)
- Prospective analysis of body mass index, physical activity, and colorectal cancer risk associated with β-catenin (CTNNB1) status. (2013) (70)
- Survival among patients with pancreatic cancer and long-standing or recent-onset diabetes mellitus. (2015) (69)
- Phase II trial of cabozantinib in patients with carcinoid and pancreatic neuroendocrine tumors (pNET). (2017) (68)
- Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survival (2017) (67)
- Feasibility of computer-based self-administered cancer-specific geriatric assessment in older patients with gastrointestinal malignancy. (2013) (64)
- Vitamin D Receptor Expression Is Associated with PIK3CA and KRAS Mutations in Colorectal Cancer (2009) (62)
- Statin Use and Colorectal Cancer Risk According to Molecular Subtypes in Two Large Prospective Cohort Studies (2011) (60)
- Phase II study of gemcitabine, oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder cancer (2014) (57)
- Phase II Study of Everolimus in Patients with Metastatic Colorectal Adenocarcinoma Previously Treated with Bevacizumab-, Fluoropyrimidine-, Oxaliplatin-, and Irinotecan-Based Regimens (2013) (55)
- Differential pre-malignant programs and microenvironment chart distinct paths to malignancy in human colorectal polyps (2021) (55)
- Sugar-sweetened beverage intake in adulthood and adolescence and risk of early-onset colorectal cancer among women (2021) (55)
- Targeting the epidermal growth factor receptor in metastatic colorectal cancer. (2008) (50)
- Diabetes, Weight Change, and Pancreatic Cancer Risk. (2020) (50)
- Predictive and prognostic analysis of PIK3CA mutation in stage III colon cancer intergroup trial. (2013) (48)
- Multi-drug inhibition of the HER pathway in metastatic colorectal cancer: Results of a phase I study of pertuzumab plus cetuximab in cetuximab-refractory patients (2014) (46)
- Intrinsic Resistance to Immune Checkpoint Blockade in a Mismatch Repair–Deficient Colorectal Cancer (2019) (45)
- A Transcriptome-Wide Association Study (TWAS) Identifies Novel Candidate Susceptibility Genes for Pancreatic Cancer. (2020) (45)
- Nut Consumption and Survival in Patients With Stage III Colon Cancer: Results From CALGB 89803 (Alliance) (2018) (45)
- Prediagnostic plasma folate and the risk of death in patients with colorectal cancer. (2008) (43)
- Lead-time trajectory of CA19-9 as an anchor marker for pancreatic cancer early detection. (2020) (42)
- Predicted vitamin D status and colon cancer recurrence and mortality in CALGB 89803 (Alliance) (2017) (41)
- Plasma 25-Hydroxyvitamin D, Vitamin D Binding Protein, and Risk of Colorectal Cancer in the Nurses' Health Study (2016) (41)
- Associations of Physical Activity With Survival and Progression in Metastatic Colorectal Cancer: Results From Cancer and Leukemia Group B (Alliance)/SWOG 80405. (2019) (41)
- Association Between Plasma Levels of Macrophage Inhibitory Cytokine-1 Before Diagnosis of Colorectal Cancer and Mortality. (2015) (40)
- Dietary Insulin Load, Dietary Insulin Index, and Colorectal Cancer (2010) (39)
- Plasma inflammatory cytokines and survival of pancreatic cancer patients (2018) (37)
- Adjuvant and Neoadjuvant Approaches in Gastric Cancer (2007) (37)
- Pancreatic Cancer Risk Associated with Prediagnostic Plasma Levels of Leptin and Leptin Receptor Genetic Polymorphisms. (2016) (37)
- Regular Use of Aspirin or Non-Aspirin Nonsteroidal Anti-Inflammatory Drugs Is Not Associated With Risk of Incident Pancreatic Cancer in Two Large Cohort Studies. (2018) (36)
- Prediagnostic Plasma 25-Hydroxyvitamin D and Pancreatic Cancer Survival. (2016) (35)
- Multicenter phase II study of tivozanib (AV-951) and everolimus (RAD001) for patients with refractory, metastatic colorectal cancer. (2013) (35)
- Statin use and pancreatic cancer risk in two prospective cohort studies (2018) (34)
- Multivitamin use is not associated with cancer recurrence or survival in patients with stage III colon cancer: findings from CALGB 89803. (2010) (34)
- PTGER2 Overexpression in Colorectal Cancer Is Associated with Microsatellite Instability, Independent of CpG Island Methylator Phenotype (2010) (33)
- Calcium intake and risk of colorectal cancer according to expression status of calcium-sensing receptor (CASR) (2017) (31)
- High-throughput dynamic BH3 profiling may quickly and accurately predict effective therapies in solid tumors (2020) (31)
- A12 The SHP2 Inhibitor RMC-4630 in Patients with KRAS-Mutant Non-Small Cell Lung Cancer: Preliminary Evaluation of a First-in-Man Phase 1 Clinical Trial (2020) (31)
- Plasma 25-Hydroxyvitamin D Levels and Survival in Patients with Advanced or Metastatic Colorectal Cancer: Findings from CALGB/SWOG 80405 (Alliance) (2019) (31)
- Circulating Metabolites and Survival Among Patients With Pancreatic Cancer. (2016) (30)
- Leucocyte telomere length, genetic variants at the TERT gene region and risk of pancreatic cancer (2016) (30)
- Genetic Predictors of Circulating 25-Hydroxyvitamin D and Risk of Colorectal Cancer (2013) (30)
- Microsatellite instability and adjuvant fluorouracil chemotherapy: a mismatch? (2010) (29)
- Vitamin D and Physical Activity in Patients With Colorectal Cancer: Epidemiological Evidence and Therapeutic Implications (2016) (29)
- Identification of a common variant with potential pleiotropic effect on risk of inflammatory bowel disease and colorectal cancer. (2015) (28)
- Analysis of Survival Among Adults With Early-Onset Colorectal Cancer in the National Cancer Database (2021) (27)
- Predicted 25(OH)D Score and Colorectal Cancer Risk According to Vitamin D Receptor Expression (2014) (26)
- Simple sugar and sugar-sweetened beverage intake during adolescence and risk of colorectal cancer precursors: Adolescent sugar intake and colorectal polyp. (2021) (26)
- Aspirin Use and Risk of Colorectal Cancer Among Older Adults. (2021) (25)
- Null Association between Vitamin D and PSA Levels among Black Men in a Vitamin D Supplementation Trial (2014) (25)
- Phase 1 dose-escalation study of momelotinib, a Janus kinase 1/2 inhibitor, combined with gemcitabine and nab-paclitaxel in patients with previously untreated metastatic pancreatic ductal adenocarcinoma (2018) (24)
- Exploiting the Therapeutic Interaction of WNT Pathway Activation and Asparaginase for Colorectal Cancer Therapy. (2020) (24)
- Association of Fusobacterium nucleatum with Specific T-cell Subsets in the Colorectal Carcinoma Microenvironment (2021) (23)
- Soluble tumour necrosis factor receptor type II and survival in colorectal cancer (2016) (22)
- Vitamin D status and survival of metastatic colorectal cancer patients: Results from CALGB/SWOG 80405 (Alliance). (2015) (22)
- Multicenter double-blind randomized phase II: FOLFOX + ziv-aflibercept/placebo for patients (pts) with chemo-naive metastatic esophagogastric adenocarcinoma (MEGA). (2016) (22)
- Prediagnostic Plasma Adiponectin and Survival among Patients with Colorectal Cancer (2015) (21)
- FGFR2 Extracellular Domain In-Frame Deletions are Therapeutically Targetable Genomic Alterations that Function as Oncogenic Drivers in Cholangiocarcinoma. (2021) (21)
- Associations of artificially sweetened beverage intake with disease recurrence and mortality in stage III colon cancer: Results from CALGB 89803 (Alliance) (2018) (20)
- Total vitamin D intake and risks of early-onset colorectal cancer and precursors. (2021) (20)
- Diabetes and Clinical Outcome in Patients With Metastatic Colorectal Cancer: CALGB 80405 (Alliance) (2019) (20)
- Association of Coffee Intake With Survival in Patients With Advanced or Metastatic Colorectal Cancer. (2020) (19)
- Prediagnosis Use of Statins Associates With Increased Survival Times of Patients With Pancreatic Cancer (2018) (19)
- Liquid biopsy reveals collateral tissue damage in cancer (2022) (18)
- Vitamin D status after colorectal cancer diagnosis and patient survival according to immune response to tumour. (2018) (17)
- Influence of dietary insulin scores on survival in colorectal cancer patients (2017) (17)
- SUNSHINE: Randomized double-blind phase II trial of vitamin D supplementation in patients with previously untreated metastatic colorectal cancer. (2017) (17)
- Dietary Insulin Load and Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803 (Alliance) (2018) (17)
- Dietary glycemic and insulin scores and colorectal cancer survival by tumor molecular biomarkers (2017) (17)
- Postdiagnosis Loss of Skeletal Muscle, but Not Adipose Tissue, Is Associated with Shorter Survival of Patients with Advanced Pancreatic Cancer (2019) (16)
- Calcium Intake and Survival after Colorectal Cancer Diagnosis (2018) (15)
- Vitamin D for Prevention and Treatment of Colorectal Cancer: What is the Evidence? (2014) (15)
- A phase II, open label study of tucatinib (ONT-380) combined with trastuzumab in patients with HER2+ metastatic colorectal cancer (mCRC)(MOUNTAINEER). (2017) (15)
- Randomized Phase II Trial of Exercise, Metformin, or Both on Metabolic Biomarkers in Colorectal and Breast Cancer Survivors (2019) (15)
- Genetic and Circulating Biomarker Data Improve Risk Prediction for Pancreatic Cancer in the General Population (2020) (15)
- Tumor Long Interspersed Nucleotide Element-1 (LINE-1) Hypomethylation in Relation to Age of Colorectal Cancer Diagnosis and Prognosis (2021) (14)
- Joint Effects of Colorectal Cancer Susceptibility Loci, Circulating 25-Hydroxyvitamin D and Risk of Colorectal Cancer (2014) (14)
- Prognostic association of PTGS2 (COX-2) over-expression according to BRAF mutation status in colorectal cancer: Results from two prospective cohorts and CALGB 89803 (Alliance) trial. (2019) (14)
- FOLFOX plus ziv‐aflibercept or placebo in first‐line metastatic esophagogastric adenocarcinoma: A double‐blind, randomized, multicenter phase 2 trial (2019) (13)
- MOUNTAINEER:open-label, phase II study of tucatinib combined with trastuzumab for HER2-positive metastatic colorectal cancer (SGNTUC-017, trial in progress). (2021) (13)
- Prospective Evaluation of Dietary and Lifestyle Pattern Indices with Risk of Colorectal Cancer in a Cohort of Younger Women. (2021) (13)
- Tumor expression of calcium sensing receptor and colorectal cancer survival: Results from the nurses’ health study and health professionals follow‐up study (2017) (12)
- US Preventive Services Task Force Recommendations for Colorectal Cancer Screening: Forty-Five Is the New Fifty. (2021) (12)
- A phase 2 clinical trial of the heat shock protein 90 (HSP 90) inhibitor ganetespib in patients with refractory advanced esophagogastric cancer (2020) (11)
- Molecular Characterization and Therapeutic Targeting of Colorectal Cancers Harboring Receptor Tyrosine Kinase Fusions (2021) (10)
- Impact of vitamin D supplementation on adiposity in African-Americans (2015) (10)
- Multicenter phase Ib/II study of everolimus (RAD001) and tivozanib (AV-951) in patients with refractory, metastatic colorectal cancer. (2012) (10)
- Grain Intake and Clinical Outcome in Stage III Colon Cancer: Results From CALGB 89803 (Alliance) (2018) (9)
- Individual participant data (IPD)-level meta-analysis of randomised controlled trials to estimate the vitamin D dietary requirements in dark-skinned individuals resident at high latitude (2021) (9)
- Effect of Exercise or Metformin on Biomarkers of Inflammation in Breast and Colorectal Cancer: A Randomized Trial (2020) (9)
- Prediagnostic Leukocyte Telomere Length and Pancreatic Cancer Survival (2019) (9)
- Prediagnostic Inflammation and Pancreatic Cancer Survival. (2021) (8)
- Obesity and efficacy of vitamin D3 supplementation in healthy black adults (2020) (8)
- Diet- and Lifestyle‐Based Prediction Models to Estimate Cancer Recurrence and Death in Patients With Stage III Colon Cancer (CALGB 89803/Alliance) (2022) (8)
- Transcriptional subtype-specific microenvironmental crosstalk and tumor cell plasticity in metastatic pancreatic cancer (2020) (8)
- Acid-suppressive medications and risk of colorectal cancer: results from three large prospective cohort studies (2020) (8)
- Family history of cancer, Ashkenazi Jewish ancestry, and pancreatic cancer risk (2019) (8)
- Intermittent dosing of RMC-4630, a potent, selective inhibitor of SHP2, combined with the MEK inhibitor cobimetinib, in a phase 1b/2 clinical trial for advanced solid tumors with activating mutations of RAS signaling (2020) (8)
- Immune cell profiles in the tumor microenvironment of early-onset, intermediate-onset, and later-onset colorectal cancer (2021) (8)
- Effects of Vitamin D Supplementation on C-peptide and 25-hydroxyvitamin D Concentrations at 3 and 6 Months (2015) (8)
- Survival in Young-Onset Metastatic Colorectal Cancer: Findings from Cancer and Leukemia Group B (Alliance)/SWOG 80405. (2021) (8)
- Nut consumption and survival in stage III colon cancer patients: Results from CALGB 89803 (Alliance). (2017) (7)
- Calcium Intake and Risk of Colorectal Cancer According to Tumor-infiltrating T Cells (2019) (7)
- Risk of hypercalcemia in blacks taking hydrochlorothiazide and vitamin D. (2014) (7)
- Prediagnostic Circulating Concentrations of Vitamin D Binding Protein and Survival among Patients with Colorectal Cancer (2020) (7)
- The tumor microenvironment drives transcriptional phenotypes and their plasticity in metastatic pancreatic cancer (2020) (6)
- Comprehensive molecular characterization of colorectal cancer reveals genomic predictors of immune cell infiltrates. (2015) (6)
- Insulin-Like Growth Factor-1 Receptor Expression and Disease Recurrence and Survival in Patients with Resected Pancreatic Ductal Adenocarcinoma (2020) (6)
- RNF43 G659fs is an oncogenic colorectal cancer mutation and sensitizes tumor cells to PI3K/mTOR inhibition (2022) (6)
- Treatment Patterns Among De Novo Metastatic Cancer Patients Who Died Within 1 Month of Diagnosis (2019) (6)
- Smoking Modifies Pancreatic Cancer Risk Loci on 2q21.3 (2021) (6)
- A phase 2 study of oral MKC-1, an inhibitor of importin-β, tubulin, and the mTOR pathway in patients with unresectable or metastatic pancreatic cancer (2012) (6)
- Genome-Wide Association Study Data Reveal Genetic Susceptibility to Chronic Inflammatory Intestinal Diseases and Pancreatic Ductal Adenocarcinoma Risk (2020) (6)
- Vitamin D supplementation: a potential therapeutic agent for metastatic colorectal cancer (2020) (5)
- Reported behavior of eating anything at anytime and risk of colorectal cancer in women (2012) (5)
- Unrestrained eating behavior and risk of digestive system cancers: a prospective cohort study. (2021) (5)
- Phase Ib study of pembrolizumab and trebananib (angiopoietin-2 inhibitor [Ang-2]): Preliminary analysis of the colorectal cancer (CRC) cohort. (2019) (5)
- Genome-Wide Gene–Diabetes and Gene–Obesity Interaction Scan in 8,255 Cases and 11,900 Controls from PanScan and PanC4 Consortia (2020) (5)
- A phase II clinical trial of ganetespib (STA-9090) in previously treated patients with advanced esophagogastric cancers. (2013) (5)
- The Diet of Higher Insulinemic Potential Is Not Associated with Worse Survival in Patients with Stage III Colon Cancer (Alliance) (2020) (4)
- Sugar-sweetened beverage, artificially sweetened beverage and sugar intake and colorectal cancer survival (2021) (4)
- Reply to PM Brannon et al. (2014) (4)
- To Treat or Not to Treat: Adjuvant Therapy for Stage II Colon Cancer in the Era of Precision Oncology. (2017) (4)
- PULSE: A randomized phase II open label study of panitumumab rechallenge versus standard therapy after progression on anti-EGFR therapy in patients with RAS wild-type metastatic colorectal cancer (mCRC). (2021) (4)
- Association of Diet Quality With Survival Among People With Metastatic Colorectal Cancer in the Cancer and Leukemia B and Southwest Oncology Group 80405 Trial (2020) (4)
- Pioneering a new care model for young-onset colorectal cancer: innovations in clinical care and scientific discovery (2020) (4)
- Reduction of parathyroid hormone with vitamin D supplementation in blacks: a randomized controlled trial (2015) (4)
- Abstract LB-235: COLOMATE: Colorectal cancer and liquid biopsy screening protocol for molecularly assigned therapy (2019) (3)
- Age at Initiation of Lower Gastrointestinal Endoscopy and Colorectal Cancer Risk Among US Women. (2022) (3)
- Trifluridine/tipiracil (FTD/TPI) and regorafenib in patients with metastatic colorectal cancer (mCRC): a retrospective study at a tertiary oncology center. (2021) (3)
- Delphi initiative for early-onset colorectal cancer (DIRECt). International Management Guidelines. (2022) (3)
- Neoadjuvant chemotherapy is associated with altered immune cell infiltration and an anti-tumorigenic microenvironment in resected pancreatic cancer. (2022) (3)
- Preexisting Type 2 Diabetes and Survival among Patients with Colorectal Cancer (2021) (3)
- Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Body Composition among Patients with Advanced or Metastatic Colorectal Cancer: A Randomized Trial (2020) (2)
- A phase II study to determine if sensory neuropathy of nab-paclitaxel can be reduced by prolonging infusion in patients with non-small cell lung cancer (NSCLC) (2007) (2)
- Impact of vitamin D supplementation on adiposity in African-Americans (2015) (2)
- Multicellular immune hubs and their organization in MMRd and MMRp colorectal cancer (2021) (2)
- Trifluridine/tipiracil (FTD/TPI) and regorafenib (REG) in patients with metastatic colorectal cancer (mCRC): A single institution retrospective study. (2019) (2)
- Temporary Ovarian Suppression With Goserelin and Ovarian Function Protection in Patients With Breast Cancer Undergoing Chemotherapy (2011) (2)
- Unrestrained eating behavior and risk of mortality: A prospective cohort study. (2021) (2)
- Influence of genetic variation in the vitamin D pathway on plasma 25-hydroxyvitamin D3 levels and survival among patients with metastatic colorectal cancer (2019) (2)
- Multicenter, randomized phase II trial of physical activity (PA), metformin (Met), or the combination on metabolic biomarkers in stage I-III colorectal (CRC) and breast cancer (BC) survivors. (2017) (2)
- PD-1 MOUNTAINEER: Open-label, phase 2 study of tucatinib combined with trastuzumab for HER2-positive metastatic colorectal cancer (SGNTUC-017, trial in progress) (2021) (2)
- Designing a multidisciplinary oral chemotherapy education and monitoring program. (2014) (1)
- A single-arm phase II trial of gemcitabine, oxaliplatin, and panitumumab in KRAS wild-type advanced biliary tract cancer. (2014) (1)
- Abstract 960: RNF43 G659fs is an oncogenic mutation in colorectal cancer and sensitizes tumor cells to PI3K/mTOR inhibition (2021) (1)
- Associations Between Unprocessed Red Meat and Processed Meat With Risk of Recurrence and Mortality in Patients With Stage III Colon Cancer (2022) (1)
- Sugar-sweetened beverage and sugar consumption and colorectal cancer incidence and mortality according to anatomic subsite. (2022) (1)
- Programmatic Precision Oncology Decision Support for Patients With Gastrointestinal Cancer (2023) (1)
- Prediagnostic plasma adiponectin and survival among patients with colorectal cancer. (2015) (1)
- 874 ASSOCIATIONS BETWEEN SCREENING LOWER ENDOSCOPY AND COLORECTAL CANCER INCIDENCE IN YOUNGER ADULTS (2021) (1)
- Acid-suppressive medications and risk of colorectal cancer: results from three large prospective cohort studies (2020) (1)
- Association of Inflammatory Biomarkers With Survival Among Patients With Stage III Colon Cancer. (2023) (1)
- Phase Ib study to test the safety and activity of pembrolizumab (anti-PD-1) and trebananib (angiopoietin-2 inhibitor [Ang-2]) in patients with advanced solid tumors: Updated analysis of the colorectal cancer (CRC) cohort. (2020) (1)
- Incident Early- and Later-Onset Type 2 Diabetes and Risk of Early- and Later-Onset Cancer: Prospective Cohort Study. (2022) (1)
- Irinotecan, cetuximab, and bevacizumab (CBI) versus irinotecan, cetuximab, and placebo (CI) in irinotecan-refractory metastatic colorectal cancer (mCRC): Results from an ACCRU network randomized phase II trial. (2020) (1)
- Effects of Polyamines on TNF α-or Tamoxifen-induced Apoptosis in Human Breast Cancer Cells (2002) (1)
- Abstract A107: Predicted vitamin D status and pancreatic cancer risk in two prospective cohort studies (2010) (1)
- Coffee Consumption and Colorectal Cancer Prognosis-Reply. (2021) (1)
- Vitamin D and colorectal cancer - A practical review of the literature. (2022) (1)
- Multicenter phase II trial of pembrolizumab (pembro) in previously-treated metastatic esophageal cancer. (2018) (1)
- 115 Tirapazamine plus cisplatin in patients (pts) with advanced non-small cell lung cancer (NSCLC)☆ (1997) (0)
- Abstract 5161: Inhibition of TBK1/IKBKE impacts tumor growth of KRAS-mutant colorectal cancers (2017) (0)
- Abstract 838: Sugar-sweetened beverage intake and risk of early-onset colorectal cancer (2021) (0)
- Abstract P076: Contribution of the microbiome to a metabolomic signature predictive of risk for pancreatic cancer (2023) (0)
- SUNSHINE: High-Dose Vitamin D Improved PFS in Colorectal Cancer (2017) (0)
- Abstract 1903: Reported behavior of eating anything at anytime and risk of colorectal cancer in women (2011) (0)
- Can an apple a day keep cancer away? (2021) (0)
- Colorectal Cancer (2022) (0)
- Tu1417: POST-DIAGNOSTIC MULTIVITAMIN SUPPLEMENT USE AND COLORECTAL CANCER SURVIVAL (2022) (0)
- Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study. (2023) (0)
- Abstract B002: History of appendectomy and colorectal cancer oncidence, overall and by intratumoral fusobacterium nucleatum status (2022) (0)
- Flavonoid intake and survival after diagnosis of colorectal cancer: A prospective study in two US cohorts. (2023) (0)
- Monogenic and Polygenic Contributions to Venous Thromboembolism (VTE) and Splanchnic Thrombosis in Patients (pts) with Pancreatic Cancer (PC) (2022) (0)
- Sugar-sweetened beverage and sugar intake during adolescence and risk of colorectal cancer precursors: a large prospective U.S. cohort study (2020) (0)
- Colorectal Cancer: Advancing Science, Improving Access, and Refining Therapy. (2022) (0)
- Abstract 3297: Prediagnostic circulating concentrations of vitamin D binding protein and survival among colorectal cancer patients (2019) (0)
- The "Scope" of Colorectal Cancer Screening in Lynch Syndrome: Is There an Optimal Interval? (2023) (0)
- 1006 Circulating 25-Hydroxyvitamin D, Vitamin D Binding Protein, and Risk of Colorectal Cancer (2014) (0)
- Cetuximab and Irinotecan With or Without Bevacizumab in Refractory Metastatic Colorectal Cancer: BOND-3, an ACCRU Network Randomized Clinical Trial (2022) (0)
- HER2 testing in colorectal cancer: Concordance analysis between breast and gastric scoring algorithms from the MOUNTAINEER trial. (2023) (0)
- Anti-tumor activity of a TBK1/IKBKE inhibitor in combination with a MEK inhibitor in KRAS mutant colorectal and non-small cell lung cancer models (2016) (0)
- Pancreatic cancer is associated with medication changes prior to clinical diagnosis (2023) (0)
- Treatment patterns among patients diagnosed with stage IV cancers who died within one month of diagnosis. (2018) (0)
- Mo1224: HELICOBACTER PYLORI SEROPOSITIVITY AND PANCREATIC CANCER RISK (2022) (0)
- Influence of dietary insulin scores on survival in patients with metastatic colorectal cancer (mCRC): Findings from CALGB (Alliance) 80405. (2021) (0)
- Prediagnostic vitamin D status and colorectal cancer survival by vitamin D-binding protein isoforms in the US cohorts. (2022) (0)
- Abstract 898: Survival for patients with early-onset colorectal cancer - An overall survival analysis from the National Cancer Database, 2004-2015 (2021) (0)
- Vitamin D supplementation: a potential therapeutic agent for metastatic colorectal cancer (2020) (0)
- Abstract 693: Calcium intake and risk of colorectal cancer according to tumor-infiltrating T cells: Results from two large U.S. prospective cohorts (2018) (0)
- Age and comorbidity association with survival outcomes in metastatic colorectal cancer: CALGB 80405 analysis. (2022) (0)
- Abstract PR009: RNF43 G659fs is an oncogenic and immune-modulating colorectal cancer mutation and sensitizes tumor cells to PI3K/mTOR inhibition (2022) (0)
- Effects of vitamin D in colorectal cancer. (2010) (0)
- Can an apple a day keep cancer away? (2021) (0)
- Abstract 5934: Weight loss and subsequent cancer diagnosis: A prospective cohort study (2022) (0)
- A common cancer at an uncommon age (2023) (0)
- Physical activity in older adults with metastatic gastrointestinal cancer: a pilot and feasibility study (2022) (0)
- Sa1932 Prediagnostic Circulating Macrophage Inhibitory Cytokine-1 (MIC-1) Is Associated With Worsened Survival Among Patients With Colorectal Cancer (2015) (0)
- A Phase 1b clinical trial of LDE225 (Sonidegib) in combination with fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFIRINOX) in previously untreated locally advanced or metastatic pancreatic adenocarcinoma (2021) (0)
- Feasibility of pharmacist co-management for patients prescribed oral anticancer therapy for gastrointestinal cancers. (2020) (0)
- Abstract PR03: Subtype-specific microenvironmental crosstalk and tumor cell plasticity in metastatic pancreatic cancer (2020) (0)
- Abstract 260: Identifying cancer drug sensitivity using live cell imaging dynamic BH3 profiling of solid tumor core biopsies (2019) (0)
- Abstract PR014: Cytokine mediated epigenetic reprogramming of CRC primary tumors drives liver metastasis (2023) (0)
- 818 Elevations of serum type III procollagen N-terminal propeptide during induction therapy predict lung toxicity in patients with lung cancer (1997) (0)
- Reply to F.V. Raimundo et al (2011) (0)
- Coffee associated with improved survival in metastatic colorectal cancer patients (2020) (0)
- Dietary fat in relation to all‐cause mortality and cancer progression and death among people with metastatic colorectal cancer: Data from CALGB 80405 (Alliance)/SWOG 80405 (2022) (0)
- Helicobacter pylori Seropositivity, ABO Blood Type, and Pancreatic Cancer Risk from 5 Prospective Cohorts. (2023) (0)
- Abstract 4478: High-throughput dynamic BH3 profiling identifies active cancer therapies in solid tumors (2019) (0)
- Feasibility of computer-based self-administered cancer-specific geriatric assessment (SA-CSGA) in older pts with gastrointestinal malignancy (GIM). (2012) (0)
- Family history of cancer, Ashkenazi Jewish ancestry, and pancreatic cancer risk (2019) (0)
- Endoscopic screening and risk of colorectal cancer according to type 2 diabetes status. (2022) (0)
- Abstract 5891: The age-dependent association of risk factors with pancreatic cancer (2022) (0)
- Novel driver genes and genomic predictors of immune infiltrates in colorectal cancer. (2016) (0)
- Factors contributing to the black/white colorectal cancer survival disparity in nonelderly patients. (2017) (0)
- Dietary fat in relation to overall and progression-free survival among patients (pts) with advanced or metastatic colorectal cancer (CRC): Data from CALGB 80405 (Alliance). (2021) (0)
- Influence of genetic variation in the vitamin D pathway on plasma 25-hydroxyvitamin D3 levels and survival among patients with metastatic colorectal cancer (2019) (0)
This paper list is powered by the following services:
Other Resources About Kimmie Ng
What Schools Are Affiliated With Kimmie Ng?
Kimmie Ng is affiliated with the following schools:
